Acera Surgical Stock
Develop a portfolio of fully synthetic surgical materials that act as nano-scale scaffold for tissue regeneration.
Sign up today and learn more about Acera Surgical Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Acera Surgical Stock
Acera Surgical, Inc. has developed a portfolio of fully synthetic surgical materials that act as resorbable scaffolds for soft tissue repair and regeneration. Acera's products are designed to improve surgical efficiency, reduce surgical complications and cost, and facilitating superior clinical outcomes.
Funding History
August 2013 | $600K |
---|---|
October 2018 | $5.1M |
Management
Founder , President & CSO
Matthew MacEwan
Manager, Program Development
Wenqi Yue
Vice President, Business Development
Julie Cochran
Director, Product Development
Tamas Kovacs
CEO
Agnes Rey-Giraud
Press
patents - Apr, 14 2024
Tissue substitute materials and methods for tissue repairpatents - Apr, 14 2024
Materials and methods for nerve repair and regenerationpatents - Apr, 14 2024
Combined macro and micro-porous hybrid-scale fiber matrixpatents - Apr, 14 2024
Particle-form hybrid-scale fiber matrixpatents - Apr, 14 2024
Tissue substitute materials and methods for tissue repair